Approximately 39 million people in the United States are affected by migraines. Despite the availability of various medications to treat migraines, not all are effective for all types of migraines. Migraines are often dismissed as just a headache, meaning many people with migraines go undiagnosed and untreated, which leads to unnecessary suffering and complications. The effectiveness of the medication can vary among individuals, and many migraine patients go untreated due to the prohibitive cost of available medications and treatments, making them less accessible to those who need them.
These studies were conducted to evaluate new potential treatments for migraines. The clients were struggling to reach their target group based on their target I/E demographic criteria.
A data science approach was employed, which involved testing, targeting, and pivoting. After reviewing the IRB-approved materials, our Ad Team began determining which channels would have the highest opportunity for qualified referrals to participants. These channels were tested, allowing us to conclude which channel(s) had the strongest results. Conversions were monitored in real time and adjusted to maximize response from the most qualified audience(s). An effective digital ad campaign for each study was launched based on our results.